What Coloplast does

Coloplast A/S is a Denmark-headquartered (Humlebaek) publicly listed medical device company founded in 1957, organized into six core business areas: Ostomy Care (SenSura Mio platform), Continence Care (SpeediCath and Luja intermittent catheters), Interventional Urology (Titan Prime penile prosthesis, Altis sling, Durasphere EXP bulking agent), Bowel Care (Peristeen transanal irrigation), Wound and Tissue Repair (Biatain dressings plus Kerecis fish-skin biologics acquired in 2023), and Voice and Respiratory Care (voice prostheses, HMEs, tubes). The company serves more than two million patients annually across 100+ countries, anchored by chronic-condition patient cohorts and institutional healthcare buyers.

The company makes money primarily through hardware sales of medical devices and consumables, distributed via direct enterprise sales subsidiaries targeting hospitals and clinics, Group Purchasing Organization contracts with Vizient, Premier, and Novation for institutional channel access, and consumer channels (pharmacies and medical supply retailers) for direct-to-patient chronic care products. Patient support is delivered through Coloplast Care and clinician-facing services through Coloplast Professional. Manufacturing is geographically diversified across Denmark, Hungary, China (Zhuhai), Portugal (Felgueiras, with a €110M expansion announced in 2025), Costa Rica, and the United States.

Coloplast's recent strategic posture reflects a shift toward higher-growth biologics and interventional urology adjacencies, executed through Kerecis (USD 1.3 billion, 2023) and Uromedica (announced 2026), alongside new product launches such as Titan Prime, Biatain Silicone Fit, Peristeen Light, and Luja for women. The company reported 7% organic revenue growth and a 28% EBIT margin in FY2024/25 and announced a new Impact4 five-year strategy in September 2025 under new CEO Gavin Wood (effective May 1, 2026), a former Johnson & Johnson executive. Operational signals include Medicare reimbursement pressure on Kerecis, ongoing FX headwinds on DKK-reported revenue, and an active capital markets posture demonstrated by a DKK 9.2 billion directed equity issue in August 2023.

Name

Coloplast

Legal name

Coloplast A/S

Website

https://coloplast.com

Company type

Public

Founded year

1957

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Coloplast A/S is a Denmark-based, publicly listed medical device company manufacturing ostomy, continence, wound, interventional urology, bowel, and voice and respiratory care products for chronic-condition patients and healthcare institutions in 100+ countries.

Ownership category

akta.pro rank

Product category

Ostomy, Continence & Wound Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414), Offices of Physicians (62111)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Ostomy Care Products (Pouches, Barriers/Wafers, Accessories, Skin Protection) (HLAHALAG)

akta.pro secondary industries

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH), Medical & Hygiene Disposables (Underpads, Disposable Washcloths, Bed Bath Products) (CRADALAK)

Keywords

• Ostomy care products
• Continence care devices
• Wound care dressings
• Medical device manufacturing
• Interventional urology

Headquarters

HQ city

Humlebæk

HQ country

Denmark

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales - B2B: Direct sales of medical devices and supplies to healthcare institutions, hospitals, clinics, and healthcare providers through subsidiaries and GPO contracts
2. Medical Device Sales - B2C: Sales of consumer healthcare products directly to patients with chronic conditions through pharmacies and direct distribution

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Coloplast manufactures and sells medical devices for intimate healthcare across six core business areas: Ostomy Care (ostomy bags including the SenSura Mio platform), Continence Care (intermittent catheters such as SpeediCath and Luja), Interventional Urology (implants, slings, and the Titan Prime penile prosthesis), Bowel Care (Peristeen transanal irrigation systems), Wound & Tissue Repair (Biatain dressings and Kerecis fish-skin biologics), and Voice and Respiratory Care (voice prostheses, HMEs, tubes and adhesives). Products are sold through both institutional healthcare channels (hospitals, clinics, GPO contracts) and direct-to-consumer channels (pharmacies, the Coloplast Care support program).

Product overview

Coloplast is a medical device company offering a portfolio of intimate healthcare solutions organized into six core business areas: Ostomy Care (ostomy bags including SenSura Mio), Continence Care (intermittent catheters including SpeediCath and Luja), Interventional Urology (implants, slings, Titan Prime penile prosthesis), Bowel Care (Peristeen transanal irrigation systems), Wound & Tissue Repair (Biatain dressings and Kerecis fish-skin biologics), and Voice & Respiratory Care. The company also provides support services through Coloplast Care (patient support) and Coloplast Professional (healthcare professional resources). Products range from disposable consumer devices to implantable prosthetics, with recent expansion through the 2023 acquisition of Kerecis biologics.

Differentiator

Problem solved

Functional benefit

Brands

• Coloplast Care: Patient support program providing practical and emotional support for people living with intimate healthcare needs
• Coloplast Professional
• SenSura Mio
• SpeediCath
• Biatain
• Peristeen
• Conveen
• Titan Prime
• Kerecis

Products and services

• Ostomy Care Ostomy bags and supporting products for people living with stomas, built on the SenSura Mio platform with double-layer adhesive technology. Sold to patients through pharmacies, medical supply retailers, and the Coloplast Care support program, and to healthcare institutions for post-surgical patient care.
• Continence Care Intermittent catheters (SpeediCath, Luja) and collecting devices for bladder management, designed to reduce urinary tract infection risk. Used by patients with neurogenic bladder and by healthcare institutions for catheterization.
• Interventional Urology Implants, slings, and surgery tools for urological conditions, including Titan Prime inflatable penile prosthesis, Virtue incontinence sling, Altis Single Incision Sling System, and Durasphere EXP bulking agent. Targeted at urologists and surgical specialists treating erectile dysfunction, stress urinary incontinence, and pelvic floor disorders.
• Bowel Care Transanal irrigation systems including Peristeen and Peristeen Light for management of neurogenic bowel dysfunction and chronic constipation. Used by patients with spinal cord injury, spina bifida, multiple sclerosis, and other neurogenic bowel conditions.
• Wound & Tissue Repair Wound dressings including the Biatain family (Biatain Soft-Hold, Biatain Ibu with ibuprofen, Biatain Silicone Fit) and Kerecis fish-skin biologics for chronic wound healing, including pressure ulcers and diabetic foot ulcers. Used by wound care clinicians, hospitals, and long-term care facilities.
• Voice and Respiratory Care Voice prostheses, Heat and Moisture Exchangers (HMEs), tubes, and adhesives for laryngectomy and respiratory care patients. Used by patients who have undergone laryngectomy and by clinicians in head and neck surgical and pulmonary care.

Quantifiable outcome

• Medical Design Excellence Award winner for Conveen Optima (2007)

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered core and major.

• VizientcoreChannel Partner/ Reseller/ DistributorGroup Purchasing Organization contract for institutional sales to Vizient member healthcare organizations
• PremiercoreChannel Partner/ Reseller/ DistributorGroup Purchasing Organization contract for institutional sales to Premier member healthcare organizations
• NovationcoreChannel Partner/ Reseller/ DistributorGroup Purchasing Organization contract for institutional sales through Novation's healthcare member network
• KerecismajorStrategic or Co-development PartnerAcquisition expanding wound care portfolio with fish skin-based regenerative tissue products
• UromedicamajorStrategic or Co-development PartnerAcquisition expanding continence care product portfolio

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ConvaTec Group: Closest direct peer: a UK-listed medical device company focused on ostomy care, continence care, advanced wound care, and infusion sets. Competes head-to-head with Coloplast across SenSura Mio, SpeediCath, and Biatain equivalents.
• Hollister Incorporated: Privately held US medical device company with a strong ostomy and continence care franchise, directly competing with Coloplast in ostomy bags and intermittent catheters.
• Smith & Nephew: Global medical device player with an Advanced Wound Management franchise that directly competes with Biatain and Kerecis. Comparable in advanced wound dressings, biologics-adjacent products, and global hospital sales channels.
• Mölnlycke Health Care: Swedish wound care and surgical solutions specialist (Mepilex, Mepitel). Overlaps with Coloplast in wound dressings and prevention, especially in the same European hospital channel.

Broad incumbents

• B. Braun: German medical device and pharma company with a sizable urology, continence, and wound care portfolio (e.g., Actreen catheters, Prontosan wound solutions). Overlaps with Coloplast in catheters and wound care but operates a much broader medtech portfolio.
• Boston Scientific: Large-cap medtech with a urology and pelvic health franchise (slings, implants, stone management) that competes with Coloplast's Interventional Urology line, including Altis and the new Titan Prime penile prosthesis.
• Baxter International: Diversified medtech with infusion systems and urology/home-care exposure. Comparable in institutional sales motion and adjacent to Coloplast's continence and home-delivered chronic-care channels.
• Stryker: Global medtech incumbent with surgical, orthopedic, and wound care adjacencies. Less direct overlap but competes for hospital capital budgets and urology/OR procedure share.

Emerging players

• Organogenesis Holdings: US-listed wound care biologics company (Apligraf, Dermagraft) competing in the same advanced wound biologics segment where Kerecis operates, useful as a biologics comp for the Kerecis business.
• Teleflex: US medtech with urology and continence catheters and surgical products that overlap with Coloplast's intermittent catheter and interventional urology portfolios.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/coloplast

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Coloplast